Wellington Management Group LLP Has $1.59 Billion Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wellington Management Group LLP trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the 4th quarter, HoldingsChannel reports. The firm owned 3,041,972 shares of the medical equipment provider’s stock after selling 73,052 shares during the quarter. Wellington Management Group LLP’s holdings in Intuitive Surgical were worth $1,587,788,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the 4th quarter valued at about $28,000. Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $31,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $491.84 on Monday. The company has a 50 day moving average price of $556.28 and a two-hundred day moving average price of $532.97. The company has a market capitalization of $175.18 billion, a PE ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Activity

In related news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last quarter. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.